Systems, components, and methods are provided for controlling the sodium and bicarbonate concentrations in a dialysate. The systems, components, and methods can use conductivity sensors to control the addition of water and bicarbonate to accurately control the final concentrations of both sodium and bicarbonate.
Sorbent-based recirculating dialysis systems often remove urea from spent dialysate by first converting the urea to carbon dioxide and ammonium ions, and then removing the ammonium ions from solution. The formation of carbon dioxide, which exists in equilibrium with bicarbonate, makes control over the bicarbonate concentration of the dialysate difficult. In a typical regenerative dialysis sorbent system sodium and bicarbonate are partially removed or generated across a sorbent cartridge, usually to unpredictable levels. Therefore, the amount of sodium and bicarbonate to add to the dialysate to achieve a desired prescription level is unpredictable and can lead to inaccurate levels.
Hence, there is a need for systems and methods for controlling the bicarbonate and sodium concentrations in the dialysate of a sorbent-based dialysis system. The need extends to systems and methods that allow for accurate control of sodium and bicarbonate without the need to directly measure and adjust the bicarbonate concentration prior to the dialysate reaching the dialyzer. There is a further need for systems and methods that can control the bicarbonate and sodium concentration throughout an entire dialysis session, even as the pH and composition of the solution leaving the sorbent cartridge changes.
The problem to be solved is controlling bicarbonate and sodium concentration in a dialysate throughout a dialysis session. The solution is to use a two-phase control, removing substantially all of the bicarbonate from solution during a first low pH phase, and then using information obtained during the first phase to control the bicarbonate and sodium concentration in a second, higher pH phase.
The first aspect relates to a system. In any embodiment, the system can include a dialysate flow path; the dialysate flow path fluidly connectable to a dialysate inlet of a dialyzer and a dialysate outlet of the dialyzer; a sorbent cartridge in the dialysate flow path; a degasser in the dialysate flow path downstream of the sorbent cartridge; a bicarbonate source fluidly connected to the dialysate flow path; a water source fluidly connected to the dialysate flow path; a first conductivity sensor downstream of the sorbent cartridge; and a control system; the control system programmed to determine a pH of a fluid exiting the sorbent cartridge; wherein: while pH of the fluid exiting the sorbent cartridge is below a preset pH, the control system is programmed to control a sodium concentration in the fluid based on a sodium prescription and a conductivity measured by the first conductivity sensor; and to control a bicarbonate concentration in the fluid based on a bicarbonate prescription.
In any embodiment, the preset pH can be about 4.8.
In any embodiment, the sorbent cartridge can include zirconium phosphate at a low pH.
In any embodiment, while the pH of the fluid exiting the sorbent cartridge is below the preset pH, the control system can be programmed to control the sodium concentration in the fluid by adding water from a water source upstream of the sorbent cartridge to a target post-sorbent conductivity setpoint.
In any embodiment, while the pH of the fluid exiting the sorbent cartridge is below the preset pH, the control system can be programmed to control the bicarbonate concentration in the fluid by adding bicarbonate from a bicarbonate source downstream of the sorbent cartridge to a target conductivity delta between a conductivity sensor after the sorbent cartridge and a conductivity sensor after the bicarbonate source.
In any embodiment, the system can include a hydrochloric acid source fluidly connected to the dialysate flow path upstream of the sorbent cartridge.
In any embodiment, the system can include at least one infusate source downstream of the sorbent cartridge.
In any embodiment, the control system can be programmed to detect release of sulfate ions from the sorbent cartridge.
In any embodiment, wherein the control system can be programmed to dilute the fluid during the release of sulfate ions.
In any embodiment, while the pH of the fluid exiting the sorbent cartridge is above a preset pH, the control system can be programmed to control the sodium concentration in the fluid by adding water from a water source upstream of the sorbent cartridge to a target pre-sorbent conductivity setpoint.
In any embodiment, the pre-sorbent conductivity can be measured with a second conductivity sensor upstream of the sorbent cartridge.
In any embodiment, the target pre-sorbent conductivity setpoint can be a conductivity measured upstream of the sorbent cartridge while the pH is below the preset pH.
In any embodiment, while the pH of the fluid exiting the sorbent cartridge is above a preset pH, the control system can be programmed to control the bicarbonate concentration in the fluid by adding bicarbonate to reach a target post-bicarbonate conductivity setpoint.
In any embodiment, the target post-bicarbonate conductivity setpoint can be based on the sodium and a bicarbonate prescription.
In any embodiment, the pH of the fluid exiting the sorbent cartridge can be measured with a pH sensor downstream of the sorbent cartridge.
In any embodiment, the pH of the fluid exiting the sorbent cartridge can be measured based on changes to a degasser output.
In any embodiment, the pH of the fluid exiting the sorbent cartridge can be measured based on a conductivity change across the sorbent cartridge measured by the first conductivity sensor and a second conductivity sensor upstream of the sorbent cartridge.
In any embodiment, the pH of the fluid exiting the sorbent cartridge can be measured based on a volume of the water added from the water source.
In any embodiment, the control system can be programmed to isolate the sorbent cartridge prior to determining the pH of the fluid exiting the sorbent cartridge.
The features disclosed as being part of the first aspect can be in the first aspect, either alone or in combination, or follow any arrangement or permutation of any one or more of the described elements. Similarly, any features disclosed as being part of the first aspect can be in a second aspect described below, either alone or in combination, or follow any arrangement or permutation of any one or more of the described elements.
The second aspect relates to a method. In any embodiment, the method can include determining a pH of a fluid exiting a sorbent cartridge of a sorbent dialysis system; and while pH of the fluid exiting the sorbent cartridge is below a preset pH, controlling a sodium concentration in the fluid based on a sodium prescription and a conductivity measured by a first conductivity sensor downstream of the sorbent cartridge; and controlling a bicarbonate concentration in the fluid based on a bicarbonate prescription.
In any embodiment, the preset pH can be about 4.8.
In any embodiment, the sorbent cartridge can include zirconium phosphate at a low pH.
In any embodiment, while the pH of the fluid exiting the sorbent cartridge is below a preset pH, the step of controlling the sodium concentration in the fluid can include adding water from a water source upstream of the sorbent cartridge to a target post-sorbent conductivity setpoint.
In any embodiment, while the pH of the fluid exiting the sorbent cartridge is below a preset pH, the step of controlling the bicarbonate concentration in the fluid can include adding bicarbonate from a bicarbonate source upstream of the sorbent cartridge and degasser to a target post-bicarbonate conductivity setpoint.
In any embodiment, the post-bicarbonate conductivity set point can be based on a conductivity increase between fluid downstream of the degasser and upstream of the bicarbonate source and fluid downstream of the bicarbonate source.
In any embodiment, the method can include the step of adding hydrochloric acid to the dialysate flow path upstream of the sorbent cartridge.
In any embodiment, while the pH of the fluid exiting the sorbent cartridge is above a preset pH, the method can include controlling the sodium concentration in the fluid by adding water from a water source upstream of the sorbent cartridge to a target pre-sorbent conductivity setpoint.
In any embodiment, target pre-sorbent conductivity setpoint can be a pre-sorbent conductivity measured while the pH is below the preset pH.
In any embodiment, while the pH of the fluid exiting the sorbent cartridge is above a preset pH, the step of controlling the bicarbonate concentration in the fluid can include adding bicarbonate to reach a post-bicarbonate conductivity setpoint.
In any embodiment, the post-bicarbonate conductivity setpoint can be based on the sodium and a bicarbonate prescription.
The features disclosed as being part of the second aspect can be in the second aspect, either alone or in combination, or follow any arrangement or permutation of any one or more of the described elements. Similarly, any features disclosed as being part of the second aspect can be in the first aspect, either alone or in combination, or follow any arrangement or permutation of any one or more of the described elements.
Unless defined otherwise, all technical and scientific terms used have the same meaning as commonly understood by one of ordinary skill in the art.
The articles “a” and “an” are used to refer to one to over one (i.e., to at least one) of the grammatical object of the article. For example, “an element” means one element or over one element.
The term “adding,” to “add,” or “addition” refers to pumping additional fluid into an existing fluid or into a component or system.
The term “bicarbonate” refers to HCO3− ions, as well as any species existing in equilibrium with bicarbonate ions, including carbonate ions and carbon dioxide.
The term “bicarbonate concentration” refers to an amount of bicarbonate dissolved in a solvent per a given amount of solvent.
A “bicarbonate prescription” is an intended bicarbonate concentration in the dialysate or blood.
The term “bicarbonate source” can refer to a source of bicarbonate ions or bicarbonate predecessors. The bicarbonate can be in acid or basic form, and can include substances that react to form bicarbonate when used in a dialysis system.
The term “blood flow rate” refers to a volume of blood moving through a system per unit of time.
The term “comprising” includes, but is not limited to, whatever follows the word “comprising.” Use of the term indicates the listed elements are required or mandatory but that other elements are optional and may be present.
The term “conductivity” refers to the inverse of the electrical resistance of a fluid.
The term “conductivity change across the sorbent cartridge” refers to a difference in conductivity of a fluid prior to the fluid entering a sorbent cartridge and after the fluid exits the sorbent cartridge.
The term “conductivity increase” refers to a positive change in conductivity of a fluid as the fluid moves through a system.
The term “conductivity sensor” refers to any component capable of measuring the electrical conductance or the electrical resistance of a fluid.
The term “consisting of” includes and is limited to whatever follows the phrase “consisting of.” The phrase indicates the limited elements are required or mandatory and that no other elements may be present.
The term “consisting essentially of” includes whatever follows the term “consisting essentially of” and additional elements, structures, acts, or features that do not affect the basic operation of the apparatus, structure or method described.
The terms “control,” “controlling,” or “controls” can refer to the ability of one component to direct the actions of a second component.
A “control system” is a device which monitors and affects the operational conditions of a given system. The operational conditions are typically referred to as output variables of the system wherein the output variables can be affected by adjusting certain input variables.
A “degasser” refers to any device, component, or system that can be used to remove one or more gases from a fluid.
The term “degasser output” can refer to an amount of gas removed from a fluid by a degasser, or to the composition of gases removed from the fluid.
The term “detect” refers to ascertaining a state of a system or component.
The terms “determining,” “determines,” and the like, generally refer to, in the broadest reasonable interpretation, any process or method for obtaining or coming to a decision, value, number, or finding, for any one or more value, output, parameter, or variable, by any means applicable to the relevant parameter being determined.
The term “dialysate” refers to any mixture that provides for passing solutes of any type through a membrane of any type. Typically, a dialysate contains a concentration of solutes to exchange solutes across a gradient to and from the dialysate during dialysis therapy.
The term “dialysate flow path” refers to a pathway through which dialysate travels during dialysis therapy.
The term “dialysate flow rate” refers to a volume of dialysate moving through a system per unit of time.
The term “dialysate inlet” refers to an opening or conduit through which dialysate can enter a component.
The term “dialysate outlet” refers to an opening or conduit through which dialysate can exit a component.
The term “dialyzer” can refer to a cartridge or container with two flow paths separated by semi-permeable membranes. One flow path can be for blood and one flow path can be for dialysate. The membranes can be in hollow fibers, flat sheets, or spiral wound or other conventional forms known to those of skill in the art. Membranes can be selected from any one or combination of materials: polysulfone, polyethersulfone, poly (methyl methacrylate), modified cellulose, or other materials known to those skilled in the art.
The term “dialyzer size” refers to the amount of fluid that can be contained within a dialyzer.
The term “dilute” means to lower a concentration of one or more solutes in solution.
The term “downstream” refers to a position of a first component in a flow path relative to a second component wherein fluid, gas, or combinations thereof, will pass by the second component prior to the first component during normal operation. The first component can be said to be “downstream” of the second component, while the second component is “upstream” of the first component.
The term “estimate” can refer to an approximation of a value for a particular parameter.
The terms “exit” or “exiting” refer to a fluid leaving a container or component.
The term “fluidly connectable” refers to the ability to provide passage of fluid, gas, or combinations thereof, from one point to another point. The ability to provide such passage can be any mechanical connection, fastening, or forming between two points to permit the flow of fluid, gas, or combinations thereof. The two points can be within or between any one or more of compartments, modules, systems, components, and rechargers, all of any type. Notably, the components that are fluidly connectable, need not be a part of a structure. For example, an outlet “fluidly connectable” to a pump does not require the pump, but merely that the outlet has the features necessary for fluid connection to the pump.
The term “fluidly connected” refers to a particular state or configuration of one or more components such that fluid, gas, or combination thereof, can flow from one point to another point. The connection state can also include an optional unconnected state or configuration, such that the two points are disconnected from each other to discontinue flow. It will be further understood that the two “fluidly connectable” points, as defined above, can form a “fluidly connected” state. The two points can be within or between any one or more of compartments, modules, systems, components, all of any type.
The term “hydrochloric acid source” refers to any source from which hydrochloric acid, or HCl, can be obtained.
The term “infusate source” refers to one or more sources of cations, such as potassium, calcium, or magnesium cations, for addition to a dialysate.
The term “isolate” refers to configuring a system such that a given component is not in fluid communication with a second given component.
The term “low pH” refers to a pH low enough that will result in substantially all bicarbonate being converted to carbon dioxide.
The term “measuring” or “to measure” can refer to determining any parameter or variable. The parameter or variable can relate to any state or value of a system, component, fluid, gas, or mixtures of one or more gases or fluids.
The term “patient bicarbonate level” refers to the bicarbonate concentration in the blood of a patient.
The term “patient size” refers to the mass or weight of a patient.
The term “patient urea level” refers to the urea concentration in the blood of a patient.
“pH” is a value equal to the negative log of the H+ ion concentration in a fluid.
The term “pH sensor” refers to any sensor or set of sensors that can be used to determine the pH of a fluid.
The term “preset” refers to a value of a parameter or state of a component or system that is determined in advance of a dialysis session.
The term “programmed,” when referring to a processor, can mean a series of instructions that cause a processor to perform certain steps.
The term “release” refers to one or more substances being added by a component to a fluid.
The term “sodium” refers to Na ions in solution.
The term “sodium concentration” refers to an amount of sodium ions dissolved in a given amount of solvent.
A “sodium prescription” is an intended sodium concentration in a dialysate or blood.
The terms “sorbent cartridge” and “sorbent container” can refer to a cartridge containing one or more sorbent materials for removing specific solutes from solution, such as urea. The term “sorbent cartridge” does not require the contents in the cartridge be sorbent based, and the contents of the sorbent cartridge can be any contents that can remove waste products from a dialysate. The sorbent cartridge may include any suitable amount of one or more sorbent materials. In certain instances, the term “sorbent cartridge” can refer to a cartridge which includes one or more sorbent materials in addition to one or more other materials capable of removing waste products from dialysate. “Sorbent cartridge” can include configurations where at least some materials in the cartridge do not act by mechanisms of adsorption or absorption. In any embodiment, a system may include a number of separate cartridges which can be physically separated or interconnected wherein such cartridges can be optionally detached and reattached as desired. The term “sulfate ions” refers to SO42
The term “target post-bicarbonate conductivity setpoint” refers to a conductivity value, measured after bicarbonate has been added to a fluid, that will result in an intended prescription for a dialysate.
The term “target post-sorbent conductivity setpoint” refers to a conductivity value, measured after a fluid has passed through a sorbent cartridge, that will result in an intended prescription for a dialysate.
The term “target pre-sorbent conductivity setpoint” refers to a conductivity value, measured before a fluid has passed through a sorbent cartridge, that will result in an intended prescription for a dialysate.
The term “ultrafiltration rate” refers to a volume of fluid removed from the blood of a patient per unit of time.
The term “upstream” refers to a position of a first component in a flow path relative to a second component wherein fluid, gas, or combinations thereof, will pass by the first component prior to the second component during normal operation. The first component can be said to be “upstream” of the second component, while the second component is “downstream” of the first component.
A “water source” can be any fluid source from which water can be obtained. The source can be any type of reservoir, fluid line, or receptacle. The water from the water source can be water with or without any dissolved solutes, including one or more buffer or ions.
“Zirconium phosphate” is a sorbent material that removes cations from a fluid, exchanging the removed cations for different cations.
After exiting the dialyzer 102, the dialysate can be pumped through dialysate flow path 101. One or more pumps (not shown) can provide the driving force necessary to control the movement of dialysate through the dialysate flow path 101. A portion of the dialysate can be drawn off as ultrafiltrate by ultrafiltration system 108. If necessary to control sodium concentration, water can be added to the dialysate from water source 110. The used dialysate can be pumped through sorbent cartridge 112 to regenerate the dialysate.
The sorbent cartridge 112 can include one or more sorbent materials to remove solutes from the dialysate, allowing the dialysate to be reused. In certain embodiments, the sorbent cartridge 112 can include activated carbon to remove creatinine, glucose, uric acid, β2-microglobulin and other non-ionic toxins, except urea, from the dialysate. The sorbent cartridge can also include urease, which converts urea to ammonium ions and carbon dioxide. Zirconium oxide in the sorbent cartridge 112 can remove phosphate, fluoride, and other anions from the dialysate. Zirconium phosphate in sorbent cartridge 112 can remove the ammonium ions generated from the breakdown of urea by the urease, as well as potassium, calcium, and magnesium cations. The cations removed by the zirconium phosphate can be exchanged for sodium and hydrogen ions.
Carbon dioxide present in the dialysate exiting the sorbent cartridge 112 can be removed by degasser 113 located downstream of the sorbent cartridge 112. Bicarbonate can be added to the dialysate from bicarbonate source 115 and cations, such as potassium, magnesium, and calcium, can be added back into the dialysate from cation infusate source 117. In certain embodiments, bypass line 120 and bypass valve 119 can be included to bypass either the dialyzer 102 or the sorbent cartridge 112.
One of skill in the art will understand that the system illustrated in
In certain embodiments, the system can control the sodium and bicarbonate concentrations in the dialysate using a two-phase approach.
When the sorbent cartridge effluent pH is below a preset pH, substantially all bicarbonate in the dialysate will be converted to carbon dioxide and subsequently removed by the degasser, effectively reducing the total CO2 or bicarbonate to a level approaching 0-mM and allowing control over both the sodium and bicarbonate concentration in the dialysate. In step 202, the system can determine a post-sorbent conductivity setpoint that will result in a desired sodium concentration. Knowing that the bicarbonate level is near zero allows an accurate conductivity value to be determined because the sorbent effluent will mainly depend on the concentration of sodium and chloride. The post-sorbent conductivity setpoint can be set based on both the sodium and bicarbonate prescriptions. For example, if a dialysate sodium of 140-mM and bicarbonate of 40-mM are desired, the sodium chloride level needed at sorbent outlet would be 100-mM and the conductivity set-point would correspond to the conductivity of a 100-mM sodium chloride solution. The remaining 40 mM of sodium will be added by addition of sodium bicarbonate after the dialysate passes through the degasser 113. Water from water source 110 can be added to the dialysate to dilute the dialysate if necessary to reach the post-sorbent conductivity setpoint in step 203. Although illustrated in
The bicarbonate concentration of the dialysate is controlled in step 204. As described, during phase 1 control, the pH of the sorbent cartridge effluent is low enough to convert substantially all bicarbonate to carbon dioxide, which is removed by degasser 113. To accurately control bicarbonate concentration in the dialysate, sodium bicarbonate from bicarbonate source 115 can be added. The system can control the addition of bicarbonate to achieve a post-bicarbonate conductivity setpoint as measured by conductivity sensor 116. The post-bicarbonate conductivity setpoint can be a fixed value based on the sodium and bicarbonate prescription. Alternatively, the post-bicarbonate conductivity setpoint can be based on achieving a target conductivity delta between the post-degasser conductivity sensor 114 and the post-bicarbonate conductivity sensor 116. For example, a bicarbonate prescription of 40-mM would require the addition of 40-mM bicarbonate from the bicarbonate source, which corresponds to a certain conductivity increase between conductivity sensor 114 and 116. Therefore, the bicarbonate source can be added to achieve the desired conductivity increase at sensor 116 relative to sensor 114. After the bicarbonate is added to the dialysate, a cation infusate can be added to control the potassium, calcium, and magnesium concentrations. In certain embodiments, the cation infusate can also include sodium. In such embodiments, the post-sorbent conductivity set point can be adjusted to account for the additional sodium.
As described, the phase 1 control over sodium and bicarbonate can continue while the sorbent effluent pH is low enough to convert substantially all the bicarbonate to carbon dioxide. In step 205, the system can monitor the sorbent cartridge effluent pH, and determine whether the sorbent cartridge effluent pH is below a preset pH. If the sorbent cartridge effluent pH is below the preset pH, the method can continue in step 203, with control over both sodium and bicarbonate. If the pH exceeds the preset pH, some level of bicarbonate can remain in the dialysate after passing through the sorbent cartridge 112 and degasser 113. The system can then switch to a phase 2 control method in step 206. In certain embodiments, the preset pH for the sorbent cartridge effluent pH can be about 4.8, which will result in substantially all the bicarbonate being removed from the dialysate.
One of skill in the art will understand that several options for determining when to switch to phase 2 control can be used. Optionally, the system can use a pH sensor at the outlet of the sorbent cartridge to measure the effluent pH. Alternatively, the system can monitor the degasser output to determine changes in the sorbent effluent pH. As the pH rises, there will be less CO2 to degas, and the degasser output will decrease. In certain embodiments, the system can detect the sorbent cartridge effluent pH state based on conductivity changes across the sorbent cartridge. As the pH of the sorbent cartridge increases, the bicarbonate concentration, and corresponding sodium concentration, increases, resulting in a smaller conductivity change across the sorbent cartridge. The system can also detect the sorbent cartridge effluent pH state based on changes in the water addition rate needed to maintain the sorbent outlet conductivity target during phase one control. As the pH rises and the sodium bicarbonate concentration increases, the sorbent outlet conductivity will increase and require an increase in water dilution to maintain the post-sorbent conductivity setpoint. Periodic isolation of the sorbent cartridge from the dialyzer and measurement of the above parameters can also be used to predict the sorbent cartridge pH state. Isolation of the dialyzer removes unknown contributions to the dialysate from the patient and results on a more accurate prediction of the pH state. To isolate the sorbent cartridge from the dialyzer, dialysate can be pumped through a bypass line, such as bypass line 120 in
Alternatively, the detection of sorbent outlet pH can be determined based on the conductivity change across the sorbent cartridge normalized to the water dilution rate needed to achieve the target post-sorbent conductivity set-point by using equation (1): (SCS−PCS)/(1-Q-H2O/QDout), wherein SCS is the conductivity measured by conductivity sensor 114, PCS is the conductivity measured by conductivity sensor, Q-H2O is the water addition rate from water source 110, and QDout is the dialysate flow rate at the dialyzer outlet 107. In addition, the SCS and PCS values used in equation (1) can be offset in time due to the volume of the sorbent cartridge and the time it takes fluid to flow from the inlet of the cartridge to the outlet. For example, a sorbent cartridge with a void volume of 4 liters will require 8 minutes for fluid to flow from the inlet to outlet at a flow rate of 500-mL/min. Therefore, the SCS value at 8 minutes should be compared to the PCS value at 0 minutes. The conductivity delta across the sorbent cartridge, SCS-PCS, is mainly influenced by the concentration of sodium bicarbonate entering the sorbent cartridge, which is determined by the prescription and patient parameters. In the low pH phase, all of the sodium bicarbonate entering the cartridge is removed resulting in a conductivity decrease. Because the SCS-PCS, or conductivity delta across the sorbent cartridge, can vary in the low pH phase due to difference in prescription or patient parameters, a plateau value can be calculated and subsequent conductivity deltas across the sorbent cartridge can be compared to the plateau value to determine when the pH has increased to the preset value. The plateau value can be determined by averaging the SCS-PCS values over a certain time, or dialysate volume, and starting at a particular dialysate volume. For example, after 40-liters of dialysate volume the SCS-PCS values, or the values calculated in Eq (1), can be averaged from to 50-liters. Then the conductivity delta across the sorbent cartridge (SCS-PCS) can be compared to the average plateau value to determine when the pH value has exceeded the preset value. For example, an increase in SCS-PCS of 0.44-mS/cm relative to the plateau value can indicate the pH has risen to a value exceeding 4.8. Values other than an increase of 0.44-mS/cm can be used depending on properties of the sorbent cartridge used or other factors such as dialysate prescription or patient parameters. The volume to start the averaging for the plateau value should start before the sorbent cartridge pH begins to rise. The volume can be based on the dialysate bicarbonate prescription. In a sorbent cartridge utilizing a zirconium phosphate sorbent as the pH controlling buffer source, the accumulation of bicarbonate through the sorbent cartridge will eventually exceed the buffering capacity of the zirconium phosphate and result in a rising pH. Therefore, a higher bicarbonate prescription will result in a sorbent cartridge pH rise sooner than a lower bicarbonate prescription. A bicarbonate prescription of 30-mM could start the plateau averaging at 60-liters and a bicarbonate prescription of 40-mM could start the plateau averaging at 40-liters, for example.
In certain embodiments, the sorbent cartridge effluent pH may remain below the preset pH value for the entire dialysis session. In such cases, the system can control the dialysate sodium and bicarbonate concentrations using the phase 1 method illustrated in
As the pH rises above the preset pH, the amount of bicarbonate, post-degassing, can increase to greater than 1 mM, and potentially up to prescription levels of 30 to 40 mM, depending on the pH at sorbent outlet and the total CO2 level in the spent dialysate entering the sorbent cartridge. During this second phase, the unpredictable bicarbonate level at sorbent outlet makes controlling to an accurate sodium and bicarbonate prescription level more difficult.
In contrast to the phase 1 control illustrated in
The phase 2 control can also rely on a predictable change in chloride concentration across the sorbent cartridge. In the case of the REDY type sorbent system, the chloride concentration can be assumed to be unchanged across the sorbent cartridge. Therefore, the PCS value determined in phase 1 is equal to the PCS value needed to achieve the desired chloride level, based on the dialysate prescription, at the sorbent inlet and subsequently the sorbent outlet, relying on the unchanging chloride concentration across the sorbent cartridge. The second aspect of control during the second phase involves adding sodium bicarbonate post-sorbent cartridge at a rate Q-Base to a conductivity value (BCS), which is the conductivity measured by conductivity sensor 116, based on the sodium and bicarbonate prescription value in step 304. Because the composition of dialysate needed after addition of sodium bicarbonate is accurately known based on the prescription, the composition error is minimized using this approach. Depending on the sorbent outlet pH and the total CO2 exiting the sorbent cartridge, the bicarbonate concentration can vary be between 1 mM and 40 mM in concentration. Typically, in phase 2 the sorbent outlet pH will increase steadily resulting in a gradual increase of the bicarbonate concentration exiting the sorbent cartridge. Therefore, the amount of sodium bicarbonate that must be added to achieve the post-bicarbonate conductivity setpoint may vary. In step 305, the dialysis session can continue until the end of the session using the phase 2 control.
In certain embodiments, the system can use phase 1 control as long as possible before the sorbent cartridge effluent pH exceeds the preset value. Delaying the transition to phase 2 control as long as possible allows for further equilibration between the patient and dialysate and determination of a more accurate sorbent inlet conductivity setpoint or profile to be used during phase two control.
In some cases, there may be a need for an additional phase of control, between the first and second phases, due to release of sulfate from the sorbent cartridge. Some sorbent cartridge designs can remove sulfate when the sorbent cartridge is in a low pH phase, but as the pH rises (above 4.5 for example), the sulfate may be released. The release of sulfate will also result in the release of sodium, to maintain charge balance. At pH values above 3, sulfates primarily exist as a divalent anion and will require two sodium ions for charge balance. The release of sodium sulfate will result in a sorbent outlet conductivity increase that will require additional dilution water (Q-H2O) to maintain the sorbent outlet conductivity at the phase 1 set-point. However, because sulfate will be present in the sorbent outlet, an adjusted conductivity setpoint can be determined based on the methods used for phase one control, except with a non-zero level for sulfate, because although sulfate is being released due to slightly higher sorbent outlet pH, while the pH is still less than 4.8, the bicarbonate concentration is still negligible. Therefore, the sodium bicarbonate addition rate can be controlled using the phase 1 control illustrated in
An example of the control approach utilized a prototype hemodialysis test system configured the same as
One of skill in the art will understand the data used in
One skilled in the art will understand that various combinations and/or modifications and variations can be made in the described systems and methods depending upon the specific needs for operation. Various aspects disclosed herein may be combined in different combinations than the combinations specifically presented in the description and accompanying drawings. Moreover, features illustrated or described as being part of an aspect of the disclosure may be used in the aspect of the disclosure, either alone or in combination, or follow a preferred arrangement of one or more of the described elements. Depending on the example, certain acts or events of any of the processes or methods described herein may be performed in a different sequence, may be added, merged, or left out altogether (e.g., certain described acts or events may not be necessary to carry out the techniques). In addition, while certain aspects of this disclosure are described as performed by a single module or unit for purposes of clarity, the techniques of this disclosure may be performed by a combination of units or modules associated with, for example, a medical device.
Number | Name | Date | Kind |
---|---|---|---|
3602222 | Herndon | Aug 1971 | A |
3608729 | Haselden | Sep 1971 | A |
3669878 | Marantz | Jun 1972 | A |
3669880 | Marantz | Jun 1972 | A |
3730183 | Goldsmith | May 1973 | A |
3754867 | Guenther | Aug 1973 | A |
3850835 | Marantz | Nov 1974 | A |
3884808 | Scott | May 1975 | A |
3989622 | Marantz | Nov 1976 | A |
4060485 | Eaton | Nov 1977 | A |
4371385 | Johnson | Feb 1983 | A |
4374382 | Markowitz | Feb 1983 | A |
4381999 | Boucher | May 1983 | A |
4460555 | Thompson | Jul 1984 | A |
4556063 | Thompson | Dec 1985 | A |
4562751 | Nason | Jan 1986 | A |
4581141 | Ash | Apr 1986 | A |
4650587 | Polak | Mar 1987 | A |
4661246 | Ash | Apr 1987 | A |
4678408 | Mason | Jul 1987 | A |
4685903 | Cable | Aug 1987 | A |
4747822 | Peabody | May 1988 | A |
4750494 | King | Jun 1988 | A |
4772560 | Attar | Sep 1988 | A |
4799493 | DuFault | Jan 1989 | A |
4826663 | Alberti | May 1989 | A |
4828693 | Lindsay | May 1989 | A |
5032265 | Jha | Jul 1991 | A |
5080653 | Voss | Jan 1992 | A |
5091642 | Chow | Feb 1992 | A |
5092886 | Dobos-Hardy | Mar 1992 | A |
5097122 | Coiman | Mar 1992 | A |
5127404 | Wyborny | Jul 1992 | A |
5141493 | Jacobsen | Aug 1992 | A |
5284470 | Beltz | Feb 1994 | A |
5302288 | Meidl | Apr 1994 | A |
5305745 | Zacouto | Apr 1994 | A |
5318750 | Lascombes | Jun 1994 | A |
5468388 | Goddard | Nov 1995 | A |
5507723 | Keshaviah | Apr 1996 | A |
5643201 | Peabody | Jul 1997 | A |
5651893 | Kenley | Jul 1997 | A |
5683432 | Goedeke | Nov 1997 | A |
5744031 | Bene | Apr 1998 | A |
5762782 | Kenley | Jun 1998 | A |
5819007 | Elghazzawi | Oct 1998 | A |
5902336 | Mishkin | May 1999 | A |
5944684 | Roberts | Aug 1999 | A |
5987352 | Klein | Nov 1999 | A |
6048732 | Anslyn | Apr 2000 | A |
6052622 | Holmstrom | Apr 2000 | A |
6058331 | King | May 2000 | A |
6156002 | Polaschegg | Dec 2000 | A |
6230059 | Duffin | May 2001 | B1 |
6248093 | Moberg | Jun 2001 | B1 |
6254567 | Treu | Jul 2001 | B1 |
6321101 | Holmstrom | Nov 2001 | B1 |
6362591 | Moberg | Mar 2002 | B1 |
6363279 | Ben-Haim | Mar 2002 | B1 |
6505075 | Weiner | Jan 2003 | B1 |
6554798 | Mann | Apr 2003 | B1 |
6555986 | Moberg | Apr 2003 | B2 |
6589229 | Connelly | Jul 2003 | B1 |
6602399 | Fromherz | Aug 2003 | B1 |
6609023 | Fischell | Aug 2003 | B1 |
6627164 | Wong | Sep 2003 | B1 |
6645191 | Knerr | Nov 2003 | B1 |
6676608 | Keren | Jan 2004 | B1 |
6689083 | Gelfand | Feb 2004 | B1 |
6706007 | Gelfand | Mar 2004 | B2 |
6711439 | Bradley | Mar 2004 | B1 |
6726647 | Sternby | Apr 2004 | B1 |
6780322 | Bissler | Aug 2004 | B1 |
6818196 | Wong | Nov 2004 | B2 |
6878283 | Thompson | Apr 2005 | B2 |
6887214 | Levin | May 2005 | B1 |
6890315 | Levin | May 2005 | B1 |
6960179 | Gura | Nov 2005 | B2 |
7074332 | Summerton | Jul 2006 | B2 |
7077819 | Goldau | Jul 2006 | B1 |
7131956 | Pirazzoli | Nov 2006 | B1 |
7175809 | Gelfand | Feb 2007 | B2 |
7208092 | Micheli | Apr 2007 | B2 |
7276042 | Polaschegg | Oct 2007 | B2 |
7399289 | Gelfand | Jul 2008 | B2 |
7404799 | Koh | Jul 2008 | B1 |
7500958 | Asbrink | Mar 2009 | B2 |
7566432 | Wong | Jul 2009 | B2 |
7575564 | Childers | Aug 2009 | B2 |
7610086 | Ke | Oct 2009 | B1 |
7674231 | Mccombie | Mar 2010 | B2 |
7704361 | Garde | Apr 2010 | B2 |
7736507 | Wong | Jun 2010 | B2 |
7744553 | Kelly | Jun 2010 | B2 |
7754852 | Burnett | Jul 2010 | B2 |
7756572 | Fard | Jul 2010 | B1 |
7775983 | Zhang | Aug 2010 | B2 |
7775986 | Roeher | Aug 2010 | B2 |
7776210 | Rosenbaum | Aug 2010 | B2 |
7785463 | Bissler | Aug 2010 | B2 |
7794141 | Perry | Sep 2010 | B2 |
7850635 | Polaschegg | Dec 2010 | B2 |
7857976 | Bissler | Dec 2010 | B2 |
7867214 | Childers | Jan 2011 | B2 |
7896831 | Sternby | Mar 2011 | B2 |
7922686 | Childers | Apr 2011 | B2 |
7922911 | Micheli | Apr 2011 | B2 |
7947179 | Rosenbaum | May 2011 | B2 |
7955291 | Sternby | Jun 2011 | B2 |
7967022 | Grant | Jun 2011 | B2 |
7981082 | Wang | Jul 2011 | B2 |
8034161 | Gura | Oct 2011 | B2 |
8070709 | Childers | Dec 2011 | B2 |
8096969 | Roberts | Jan 2012 | B2 |
8105260 | Tonelli | Jan 2012 | B2 |
8183046 | Lu | May 2012 | B2 |
8187250 | Roberts | May 2012 | B2 |
8197439 | Wang | Jun 2012 | B2 |
8202241 | Karakama | Jun 2012 | B2 |
8246826 | Wilt | Aug 2012 | B2 |
8273049 | Demers | Sep 2012 | B2 |
8282828 | Wallenas | Oct 2012 | B2 |
8292594 | Tracey | Oct 2012 | B2 |
8313642 | Yu | Nov 2012 | B2 |
8317492 | Demers | Nov 2012 | B2 |
8357113 | Childers | Jan 2013 | B2 |
8366316 | Kamen | Feb 2013 | B2 |
8366655 | Kamen | Feb 2013 | B2 |
8404091 | Ding | Mar 2013 | B2 |
8409441 | Wilt | Apr 2013 | B2 |
8496809 | Roger | Jul 2013 | B2 |
8499780 | Wilt | Aug 2013 | B2 |
8500676 | Jansson | Aug 2013 | B2 |
8512271 | Moissl | Aug 2013 | B2 |
8518260 | Raimann | Aug 2013 | B2 |
8521482 | Akonur | Aug 2013 | B2 |
8535525 | Heyes | Sep 2013 | B2 |
8560510 | Brueggerhoff | Oct 2013 | B2 |
8580112 | Updyke | Nov 2013 | B2 |
8597227 | Childers | Dec 2013 | B2 |
8696626 | Kirsch | Apr 2014 | B2 |
8903492 | Soykan | Dec 2014 | B2 |
8926542 | Gerber | Jan 2015 | B2 |
20020016550 | Sweeney | Feb 2002 | A1 |
20020042561 | Schulman | Apr 2002 | A1 |
20020112609 | Wong | Aug 2002 | A1 |
20030028089 | Galley | Apr 2003 | A1 |
20030069481 | Hervy | Apr 2003 | A1 |
20030080059 | Peterson | May 2003 | A1 |
20030097086 | Gura | May 2003 | A1 |
20030105435 | Taylor | Jun 2003 | A1 |
20030113931 | Pan | Jun 2003 | A1 |
20030114787 | Gura | Jun 2003 | A1 |
20030187479 | Thong | Oct 2003 | A1 |
20040019312 | Childers | Jan 2004 | A1 |
20040060865 | Callan | Apr 2004 | A1 |
20040068219 | Summerton | Apr 2004 | A1 |
20040099593 | DePaolis | May 2004 | A1 |
20040147900 | Polaschegg | Jul 2004 | A1 |
20040168969 | Sternby | Sep 2004 | A1 |
20040215090 | Erkkila | Oct 2004 | A1 |
20050065760 | Murtfeldt | Mar 2005 | A1 |
20050113796 | Taylor | May 2005 | A1 |
20050126961 | Bissler | Jun 2005 | A1 |
20050131331 | Kelly | Jun 2005 | A1 |
20050126998 | Childers | Jul 2005 | A1 |
20050150832 | Tsukamoto | Jul 2005 | A1 |
20050214863 | McDevitt | Sep 2005 | A1 |
20050234354 | Rowlandson | Oct 2005 | A1 |
20050234357 | Xue | Oct 2005 | A1 |
20050234381 | Niemetz | Oct 2005 | A1 |
20050234534 | Rowlandson | Oct 2005 | A1 |
20050236330 | Nier | Oct 2005 | A1 |
20050265895 | Kopelman | Dec 2005 | A1 |
20050274658 | Rosenbaum | Dec 2005 | A1 |
20060025661 | Sweeney | Feb 2006 | A1 |
20060025748 | Ye | Feb 2006 | A1 |
20060217771 | Soykan | Feb 2006 | A1 |
20060058731 | Burnett | Mar 2006 | A1 |
20060191850 | Bosetto | Aug 2006 | A1 |
20060195064 | Plahey | Aug 2006 | A1 |
20060226079 | Mori | Oct 2006 | A1 |
20060241709 | Soykan | Oct 2006 | A1 |
20060247548 | Sarkar | Nov 2006 | A1 |
20060264894 | Moberg | Nov 2006 | A1 |
20070007208 | Brugger | Jan 2007 | A1 |
20070038138 | Gill | Feb 2007 | A1 |
20070066928 | Lannoy | Mar 2007 | A1 |
20070073168 | Zhang | Mar 2007 | A1 |
20070138011 | Hofmann | Jun 2007 | A1 |
20070161113 | Ash | Jul 2007 | A1 |
20070175827 | Wariar | Aug 2007 | A1 |
20070179431 | Roberts | Aug 2007 | A1 |
20070213653 | Childers | Sep 2007 | A1 |
20070213665 | Curtin | Sep 2007 | A1 |
20070215545 | Bissler | Sep 2007 | A1 |
20070255250 | Moberg | Nov 2007 | A1 |
20070276270 | Tran | Nov 2007 | A1 |
20080006570 | Gura | Jan 2008 | A1 |
20080021337 | Li | Jan 2008 | A1 |
20080053905 | Brugger | Mar 2008 | A9 |
20080067132 | Ross | Mar 2008 | A1 |
20080093276 | Roger | Apr 2008 | A1 |
20080200866 | Prisco | Aug 2008 | A1 |
20080215247 | Tonelli | Sep 2008 | A1 |
20080253427 | Kamen | Oct 2008 | A1 |
20090020471 | Tsukamoto | Jan 2009 | A1 |
20090036825 | Petersen | Feb 2009 | A1 |
20090101577 | Fulkerson | Apr 2009 | A1 |
20090124869 | Hu | May 2009 | A1 |
20090124963 | Hogard | May 2009 | A1 |
20090127193 | Updyke | May 2009 | A1 |
20090171261 | Sternby | Jul 2009 | A1 |
20090264776 | Vardy | Oct 2009 | A1 |
20090275849 | Stewart | Nov 2009 | A1 |
20090275883 | Chapman | Nov 2009 | A1 |
20090281484 | Childers | Nov 2009 | A1 |
20090282980 | Gura | Nov 2009 | A1 |
20090314063 | Sternby | Dec 2009 | A1 |
20100004588 | Yeh | Jan 2010 | A1 |
20100010429 | Childers | Jan 2010 | A1 |
20100042035 | Moissl | Feb 2010 | A1 |
20100076398 | Scheurer | Mar 2010 | A1 |
20100078381 | Merchant | Apr 2010 | A1 |
20100078387 | Wong | Apr 2010 | A1 |
20100084330 | Wong | Apr 2010 | A1 |
20100087771 | Karakama | Apr 2010 | A1 |
20100094158 | Solem | Apr 2010 | A1 |
20100113891 | Barrett | May 2010 | A1 |
20100114012 | Sandford | May 2010 | A1 |
20100137693 | Porras | Jun 2010 | A1 |
20100137782 | Jansson | Jun 2010 | A1 |
20100168546 | Kamath | Jul 2010 | A1 |
20100217180 | Akonur | Aug 2010 | A1 |
20100217181 | Roberts | Aug 2010 | A1 |
20100224492 | Ding | Sep 2010 | A1 |
20100234795 | Wallenas | Sep 2010 | A1 |
20100241045 | Kelly | Sep 2010 | A1 |
20100264086 | Noack | Oct 2010 | A1 |
20100312172 | Hoffman | Dec 2010 | A1 |
20110017665 | Updyke | Jan 2011 | A1 |
20110048949 | Ding et al. | Mar 2011 | A1 |
20110066006 | Banet | Mar 2011 | A1 |
20110066043 | Banet | Mar 2011 | A1 |
20110071465 | Wang | Mar 2011 | A1 |
20110077574 | Sigg | Mar 2011 | A1 |
20110077575 | Kraemer | Mar 2011 | A1 |
20110079558 | Raimann | Apr 2011 | A1 |
20110081728 | Putnam | Apr 2011 | A1 |
20110087187 | Beck | Apr 2011 | A1 |
20110100909 | Stange | May 2011 | A1 |
20110106003 | Childers | May 2011 | A1 |
20110130666 | Dong | Jun 2011 | A1 |
20110137136 | Kotanko | Jun 2011 | A1 |
20110141116 | Dalesch | Jun 2011 | A1 |
20110144570 | Childers | Jun 2011 | A1 |
20110184340 | Tan | Jul 2011 | A1 |
20110208105 | Brandl | Aug 2011 | A1 |
20110272337 | Palmer | Nov 2011 | A1 |
20110301447 | Park | Dec 2011 | A1 |
20110301472 | Grober | Dec 2011 | A1 |
20120016228 | Kroh | Jan 2012 | A1 |
20120083729 | Childers | Apr 2012 | A1 |
20120085707 | Beiriger | Apr 2012 | A1 |
20120115248 | Ansyln | May 2012 | A1 |
20120135396 | McDevitt | May 2012 | A1 |
20120181230 | Kloeffel | Jul 2012 | A1 |
20120220528 | VanAntwerp | Aug 2012 | A1 |
20120258545 | Ash | Oct 2012 | A1 |
20120258546 | Marran | Oct 2012 | A1 |
20120259276 | Childers | Oct 2012 | A1 |
20120273354 | Orhan et al. | Nov 2012 | A1 |
20120273415 | Gerber | Nov 2012 | A1 |
20120273420 | Gerber | Nov 2012 | A1 |
20120277546 | Soykan | Nov 2012 | A1 |
20120277551 | Gerber | Nov 2012 | A1 |
20120277552 | Gerber | Nov 2012 | A1 |
20120277604 | Gerber | Nov 2012 | A1 |
20120277650 | Gerber | Nov 2012 | A1 |
20120277655 | Gerber | Nov 2012 | A1 |
20120277722 | Gerber | Nov 2012 | A1 |
20120283581 | Olde et al. | Nov 2012 | A1 |
20120303079 | Mahajan | Nov 2012 | A1 |
20130037465 | Heyes | Feb 2013 | A1 |
20130062265 | Balschat | Mar 2013 | A1 |
20130116578 | An | May 2013 | A1 |
20130168316 | Noguchi | Jul 2013 | A1 |
20130193073 | Hogard | Aug 2013 | A1 |
20130199998 | Kelly | Aug 2013 | A1 |
20130211730 | Wolff | Aug 2013 | A1 |
20130213890 | Kelly | Aug 2013 | A1 |
20130228517 | Roger | Sep 2013 | A1 |
20130231607 | Roger | Sep 2013 | A1 |
20130248426 | Pouchoulin | Sep 2013 | A1 |
20130274642 | Soykan | Oct 2013 | A1 |
20130324915 | (Krensky)Britton | Dec 2013 | A1 |
20130330208 | Ly | Dec 2013 | A1 |
20130331774 | Farrell | Dec 2013 | A1 |
20140018727 | Burbank | Jan 2014 | A1 |
20140018728 | Plahey | Jan 2014 | A1 |
20140042092 | Akonur | Feb 2014 | A1 |
20140065950 | Mendelsohn | Mar 2014 | A1 |
20140088442 | Soykan | Mar 2014 | A1 |
20140110340 | White | Apr 2014 | A1 |
20140110341 | White | Apr 2014 | A1 |
20140158538 | Collier | Jun 2014 | A1 |
20140158588 | Pudil | Jun 2014 | A1 |
20140158623 | Pudil | Jun 2014 | A1 |
20140190876 | Meyer | Jul 2014 | A1 |
20140216250 | Meyer | Aug 2014 | A1 |
20140217028 | Pudil | Aug 2014 | A1 |
20140217029 | Meyer | Aug 2014 | A1 |
20140217030 | Meyer | Aug 2014 | A1 |
20140220699 | Pudil | Aug 2014 | A1 |
20140314625 | Clift | Oct 2014 | A1 |
20150032023 | Soykan | Jan 2015 | A1 |
20150080682 | Gerber | Mar 2015 | A1 |
20150088047 | Gerber | Mar 2015 | A1 |
20150144539 | Pudil | May 2015 | A1 |
20150148697 | Burnes | May 2015 | A1 |
20150149096 | Soykan | May 2015 | A1 |
20150250427 | Soykan | Sep 2015 | A1 |
20150343126 | Merchant | Dec 2015 | A1 |
20150352269 | Gerber | Dec 2015 | A1 |
20150367054 | Gerber | Dec 2015 | A1 |
20160023467 | Smith | Feb 2016 | A1 |
20160206801 | Gerber | Jul 2016 | A1 |
20160331884 | Sigg | Nov 2016 | A1 |
20190134289 | Pudil | May 2019 | A1 |
Number | Date | Country |
---|---|---|
101193667 | Jun 2008 | CN |
3224823 | Jan 1984 | DE |
0272414 | Oct 1991 | EP |
0330892 | Jul 1994 | EP |
1085295 | Nov 2001 | EP |
1281351 | Feb 2003 | EP |
2308526 | Oct 2003 | EP |
1364666 | Nov 2003 | EP |
0906768 | Feb 2004 | EP |
1691863 | Apr 2005 | EP |
2116269 | Feb 2008 | EP |
1450879 | Oct 2008 | EP |
1514562 | Apr 2009 | EP |
2219703 | May 2009 | EP |
1592494 | Jun 2009 | EP |
2398529 | Nov 2010 | EP |
2100553 | Aug 2011 | EP |
1345856 | Mar 2013 | EP |
2344220 | Apr 2013 | EP |
1351756 | Jul 2013 | EP |
2190498 | Jul 2013 | EP |
1582226 | Jan 2016 | EP |
S63-143077 | Nov 1987 | JP |
2002533170 | Oct 2002 | JP |
2003235965 | Aug 2003 | JP |
2005-533573 | Nov 2005 | JP |
1995003839 | Feb 1995 | WO |
WO 1998054563 | Dec 1998 | WO |
0057935 | Oct 2000 | WO |
WO2000057935 | Oct 2000 | WO |
2000066197 | Nov 2000 | WO |
200170307 | Sep 2001 | WO |
2001085295 | Sep 2001 | WO |
2002013691 | Feb 2002 | WO |
2003043680 | May 2003 | WO |
2003051422 | Jun 2003 | WO |
2004008826 | Jan 2004 | WO |
2004009156 | Jan 2004 | WO |
2004009158 | Jan 2004 | WO |
2004030716 | Apr 2004 | WO |
2004030717 | Apr 2004 | WO |
2004064616 | Aug 2004 | WO |
2005033701 | Apr 2005 | WO |
2005061026 | Jul 2005 | WO |
2005123230 | Dec 2005 | WO |
2006011009 | Feb 2006 | WO |
2006017446 | Feb 2006 | WO |
2007038347 | Apr 2007 | WO |
2007089855 | Aug 2007 | WO |
2008037410 | Apr 2008 | WO |
2009026603 | Dec 2008 | WO |
2009024566 | Feb 2009 | WO |
2009061608 | May 2009 | WO |
2009094184 | Jul 2009 | WO |
2010024963 | Mar 2010 | WO |
2010028860 | Mar 2010 | WO |
2010033314 | Mar 2010 | WO |
2010033699 | Mar 2010 | WO |
2010077851 | Jul 2010 | WO |
2010096659 | Oct 2010 | WO |
2010121820 | Oct 2010 | WO |
2011025705 | Mar 2011 | WO |
2011026645 | Mar 2011 | WO |
WO 2011132046 | Oct 2011 | WO |
2011137693 | Nov 2011 | WO |
WO2011161056 | Dec 2011 | WO |
2012042323 | Apr 2012 | WO |
2012050781 | Apr 2012 | WO |
2012051996 | Apr 2012 | WO |
2012073420 | Jul 2012 | WO |
2012148781 | Nov 2012 | WO |
2012148786 | Nov 2012 | WO |
2012148787 | Nov 2012 | WO |
2012148789 | Nov 2012 | WO |
2012162515 | Nov 2012 | WO |
WO2012148788 | Nov 2012 | WO |
WO 20120148784 | Nov 2012 | WO |
2012172398 | Dec 2012 | WO |
2013019179 | Feb 2013 | WO |
2013019994 | Feb 2013 | WO |
2013025844 | Feb 2013 | WO |
2013028809 | Feb 2013 | WO |
2013101292 | Jul 2013 | WO |
2013103607 | Jul 2013 | WO |
2013103906 | Jul 2013 | WO |
2013110906 | Aug 2013 | WO |
2013110919 | Aug 2013 | WO |
2013114063 | Aug 2013 | WO |
2013121162 | Aug 2013 | WO |
2013140346 | Sep 2013 | WO |
2013141896 | Sep 2013 | WO |
14066254 | May 2014 | WO |
14066255 | May 2014 | WO |
14077082 | May 2014 | WO |
2014121167 | Aug 2014 | WO |
2014121169 | Aug 2014 | WO |
2014211162 | Aug 2014 | WO |
2014211163 | Aug 2014 | WO |
WO 20140121161 | Aug 2014 | WO |
WO2012081221 | Jun 2015 | WO |
WO 20150159280 | Oct 2015 | WO |
Entry |
---|
[NPL105] Brynda, et. al., The detection of toman 2-microglebuiin by grating coupler immunosensor with three dimensional antibody networks. Biosensors & Bioelectronics, 1999, 363-368, 14(4). |
[NPL10] Wheaton, et al., Dowex Ion Exchange Resins-Fundamentals of Ion Exchange; Jun. 2000, pp. 1-9. http://www.dow.com/scripts/litorder.asp?filepath=liquidseps/pdfs/noreg/177-01837.pdf. |
[NPL111] Zhong, et. al., Miniature urea sensor based on H(+)-ion sensitive field effect transistor and its application in clinical analysis, Chin. J. Biotechnol., 1992, 57-65. 8(1). |
[NPL121] Roberts M, The regenerative dialysis (REDY) sorbent system. Nephrology, 1998, 275-278:4. |
[NPL142] Hemametrics, Crit-Line Hematocrit Accuracy, 2003, 1-5, vol. 1, Tech Note No. 11 (Rev. D). |
[NPL144] Weissman, S., et al., Hydroxyurea-induced hepatitis in human immunodeficiency virus-positive patients. Clin. Infec. Dis, (Jul. 29, 1999): 223-224. |
[NPL14] Foley, et al., Long Interdialytic Interval and Martality among Patients Receiving Hemodialysis, N Engl Jrnl Med. 2011:365(12):1099-1107. |
[NPL169] Wang, Fundamentals of intrathoracic impedance monitoring in heart failure, Am. J. Cardiology, 2007, 3G-10G: Suppl. |
[NPL176] Bleyer, et al., Sudden and cardiac death rated in hemodialysis patients, Kidney International. 1999, 1553-1559: 55. |
[NPL205] Culleton, BR et al. Effect of Frequent Nocturnal Hemodialysis vs. Conventional Hemodialysis on Left Ventricular Mass and Quality of Life. 2007 Journal of the American Medical Association 298 (11), 1291-1299. |
[NPL230] Redfield, et. al., Restoration of renal response to atrial natriuretic factor in experimental low-output heat failure, Am. J. Physiol., Oct. 1, 1989, R917-923:257. |
[NPL231] Rogoza, et. al., Validation of A&D UA-767 device for the self-measurement of blood pressure, Blood Pressure Monitoring, 2000, 227-231, 5(4). |
[NPL234] Lima, et. al., An electrochemical sensor based on nanostructure hollandite-type manganese oxide for detection of potassium ion, Sensors, Aug. 24, 2009, 6613-8625, 9. |
[NPL235] Maclean, et. al., Effects of hindlimb contraction on pressor and muscle interstitial metabolite responses in the cat, J. App. Physiol., 1998, 1583-1592, 85(4). |
[NPL26] Overgaard, et. al., Activity-induced recovery of excitability in K+-depressed rat soleus muscle, Am. J. P 280: R48-R55, Jan. 1, 2001. |
[NPL27] Overgaard et. al., Relations between excitability and contractility in rate soleusmuscle: role of the NA+-K+ pump and NA+-K-S gradients. Journal of Physiology, 1999, 215-225, 518(1). |
[NPL306] Coast, et al. 1990, An approach to Cardiac Arrhythmia analysis Using Hidden Markov Models, IEEE Transactions On Biomedical Engineering. 1990, 37(9):826-835. |
[NPL309] Weiner, et. al., Article: Cardiac Function and Cardiovascular Disease in Chronic Kidney Disease, Book: Primer on Kidney Diseases (Author: Greenberg, et al.), 2009,499-505, 5th Ed., Saunders Elsevier, Philadelphia, PA. |
[NPL322] Velasco, Optimal Fluid Control can Normalize Cardiovascular Risk Markers and Limit Left Ventricular Hypertrophy in Thrice Weekly Dialysis Patients, Hemodialysis Intenational, 16:465-472, 2012. |
[NPL323] Whitman, CKD and Sudden Cardiac Death: Epidemiology, Mechanisms, and Therapeutic Approaches, J Am Soc Nephrol, 23:1929-1939, 2012. |
[NPL324] Hall, Hospitalization for Congestive Heart Failure: United States, 2000-2010, NCHS Data Brief, No. 108, Oct. 2012. |
[NPL325] Albert, Fluid Management Strategies in Heart Failure, Critical Care Nurse, 32:20-32, 2012. |
[NPL328] Genovesi, et al., Nephrology, Dialysis, Transplantation 2009; 24(8):2529-2536. |
[NPL32] Secemsky, et al., High prevalence of cardiac autonomic dysfunction and T-wave alternans in dialysis patients. Heart Rhythm, Apr. 2011, 592-598 : vol. 8, No. 4. |
[NPL35] Wei, et. al., Fullerene-cryptand coated piezoelectric crystal urea sensor based on urease, Analytica Chimica Acta, 2001,77-85:437. |
[NPL376] Gambro AK 96 Dialysis Machine Operators Manual, Dec. 2012. p. 1-140. |
[NPL376] Gambro AK 96 Dialysis Machine Operators Manual, Dec. 2012. p. 141-280. |
[NPL376] Gambro AK 96 Dialysis Machine Operators Manual, Dec. 2012. p. 281-420. |
[NPL376] Gambro AK 96 Dialysis Machine Operators Manual, Dec. 2012. p. 421-534. |
[NPL383] Leifer et al., A Study on the Temperature Variation of Rise Velocity for Large Clean Bubbles, J. Atmospheric & Oceanic Tech., vol. 17, pp. 1392-1402, Oct. 2000. |
[NPL384] Talaia, Terminal Velocity of a Bubble Rise in a Liquid Column, World Acad. of Sci., Engineering & Tech., vol. 28, pp. 264-268, Published Jan. 1, 2007. |
[NPL386] The FHN Trial Group. In-Center. Hemodialysis Six Times per Week versus Three Times per Week, New England Journal of Medicine, 2010 Abstract. |
[NPL46] Siegenthaler, et al., Pulmonary fluid status monitoring with intrathoracic impedance, Journal of Clinical Monitoring and Computing, 24:449-451, published Jan. 12, 2011. |
[NPL494] John Wm Agar: Review: Understanding sorbent dialysis systems, Nephrology, vol. 15, No. 4, Jun. 1, 2010, pp. 406-411. |
[NPL632] Lakerveld et al, Primary prevention of diabetes mellitus type 2 and cardiovascular diseases using a cognitive behavior program aimed at lifestyle changes in people at risk: Design of a randomized controlled trial, 2008, BMC Endocrine Disorders, 8(6): 1-19. |
[NPL633] Gordhandas et al., Real-Time Extraction and Analysis of Key Morphological Features in the Electrocardiogram, for Data Compression and Clinical Decision Support, 2004, Computational Physiology, pp. 15-18. |
[NPL90] Nedelkov, et. al., Design of buffer exchange surfaces and sensor chips for biosensor chip mass spectrometry, Proteomics, 2002, 441-446, 2(4). |
[NPL] Green et. al., Sudden Cardiac Death in Hemodialysis Patients: an In-Depth Review , Am J Kidney Dis 57(6)921:929; published Apr. 18, 2011. |
[NPL] Rajan et al. Generalized Feature Extraction for Time-Varying Autoregressive Models, IEEE Transacion Signal Processing vol. 44, No. 10; published Oct. 1, 1996. |
Laurent, Jeanpierre, “Continuous Monitoring of Dynamic Systems: Application to Monitoring of Dialyzed Patients” Oct. 30, 2004, received from internet: http://laurent.jeanpierre1.free.fr/recherche/papiers/aista2004.pdf. |
Wollenstein, et al, “Colorimetric gas sensors for the detection of ammonia, nitrogen dioxide, and carbon monoxide: current status and research trends”, Sensor and Test Conference 2011, Jan. 2, 2011, pp. 562-567. |
Number | Date | Country | |
---|---|---|---|
20230149607 A1 | May 2023 | US |